These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35001672)

  • 1. Outcome of Antibody-Mediated Fetal Heart Disease With Standardized Anti-Inflammatory Transplacental Treatment.
    Mawad W; Hornberger L; Cuneo B; Raboisson MJ; Moon-Grady AJ; Lougheed J; Diab K; Parkman J; Silverman E; Jaeggi E
    J Am Heart Assoc; 2022 Feb; 11(3):e023000. PubMed ID: 35001672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy.
    Trucco SM; Jaeggi E; Cuneo B; Moon-Grady AJ; Silverman E; Silverman N; Hornberger LK
    J Am Coll Cardiol; 2011 Feb; 57(6):715-23. PubMed ID: 21292131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
    Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
    Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological characteristics of fetal atrioventricular block.
    Zhao H; Cuneo BF; Strasburger JF; Huhta JC; Gotteiner NL; Wakai RT
    J Am Coll Cardiol; 2008 Jan; 51(1):77-84. PubMed ID: 18174041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.
    Jaeggi ET; Fouron JC; Silverman ED; Ryan G; Smallhorn J; Hornberger LK
    Circulation; 2004 Sep; 110(12):1542-8. PubMed ID: 15353508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies.
    Sonesson SE; Ambrosi A; Wahren-Herlenius M
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):87-95. PubMed ID: 30620419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetophysiologic and echocardiographic comparison of blocked atrial bigeminy and 2:1 atrioventricular block in the fetus.
    Wiggins DL; Strasburger JF; Gotteiner NL; Cuneo B; Wakai RT
    Heart Rhythm; 2013 Aug; 10(8):1192-8. PubMed ID: 23619035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient fetal atrioventricular block: A series of four cases and approach to management.
    Kikano SD; Killen SAS
    J Cardiovasc Electrophysiol; 2022 Oct; 33(10):2228-2232. PubMed ID: 35924469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case with fetal autoimmune heart block and KNCH2 variant-induced long QT syndrome: a controversial opinion on prenatal management strategy.
    Wei L; Wu J; Xie P; Liu X; Hua Y; Zhou K; Wang C; Li Y
    BMC Cardiovasc Disord; 2023 Mar; 23(1):159. PubMed ID: 36973673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience.
    O'Leary ET; Alexander ME; Bezzerides VJ; Drogosz M; Economy KE; Friedman KG; Pickard SS; Tworetzky W; Mah DY
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1105-1113. PubMed ID: 32100356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.
    Izmirly PM; Saxena A; Kim MY; Wang D; Sahl SK; Llanos C; Friedman D; Buyon JP
    Circulation; 2011 Nov; 124(18):1927-35. PubMed ID: 21969015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Transplacental Dexamethasone Therapy on Fetal Immune-Mediated Complete Heart Block.
    Saito M; Silverman E; Golding F; Guerra V; Hiraki L; Thakur V; Jaeggi E
    Fetal Diagn Ther; 2021; 48(3):183-188. PubMed ID: 33592603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies.
    Cuneo BF; Sonesson SE; Levasseur S; Moon-Grady AJ; Krishnan A; Donofrio MT; Raboisson MJ; Hornberger LK; Van Eerden P; Sinkovskaya E; Abuhamad A; Arya B; Szwast A; Gardiner H; Jacobs K; Freire G; Howley L; Lam A; Kaizer AM; Benson DW; Jaeggi E
    J Am Coll Cardiol; 2018 Oct; 72(16):1940-1951. PubMed ID: 30309472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review.
    Hutter D; Silverman ED; Jaeggi ET
    Scand J Immunol; 2010 Sep; 72(3):235-41. PubMed ID: 20696021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients.
    Eliasson H; Sonesson SE; Sharland G; Granath F; Simpson JM; Carvalho JS; Jicinska H; Tomek V; Dangel J; Zielinsky P; Respondek-Liberska M; Freund MW; Mellander M; Bartrons J; Gardiner HM;
    Circulation; 2011 Nov; 124(18):1919-26. PubMed ID: 21986286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of transplacental treatment for fetal congenital bradyarrhythmia: – nationwide survey in Japan –.
    Miyoshi T; Maeno Y; Sago H; Inamura N; Yasukohchi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Shozu M; Nii M; Kato H; Hayashi S; Hagiwara A; Omoto A; Shimizu W; Shiraishi I; Sakaguchi H; Nishimura K; Ueda K; Katsuragi S; Ikeda T
    Circ J; 2012; 76(2):469-76. PubMed ID: 22199137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block.
    Fesslova V; Vignati G; Brucato A; De Sanctis M; Butera G; Pisoni MP; Chiappa E; Acaia B; Meroni PL
    Cardiol Young; 2009 Jun; 19(3):282-90. PubMed ID: 19383179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies.
    Keller SB; Cohen J; Moon-Grady A; Cuneo B; Paul E; Coll AC; Campbell M; Srivastava S
    Ultrasound Obstet Gynecol; 2023 Jul; 62(1):148-151. PubMed ID: 36806323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal outcome in fetuses with heterotaxy syndrome and atrioventricular block or bradycardia.
    Escobar-Diaz MC; Tworetzky W; Friedman K; Lafranchi T; Fynn-Thompson F; Alexander ME; Mah DY
    Pediatr Cardiol; 2014 Aug; 35(6):906-13. PubMed ID: 24509635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.